Calpain inhibitor I and colonic inflammation induced by DNBS in the rat

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.

Expert opinion on pharmacotherapy·2001

Orlistat in the treatment of obesity.

Expert opinion on pharmacotherapy·2001

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

Gut·2000

The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis.

Gastroenterology·2000

Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss.

Clinical science (London, England : 1979)·1998

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998

Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling.

Gut·2026

Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.

Gut·2026

Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.

Gut·2026

Prior endoscopic surveillance and diagnosis of Barrett-related dysplasia and cancer: evidence from a nationwide Dutch cohort.

Gut·2026

Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Gut·2026

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC.

Gut·2026

Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.

medRxiv : the preprint server for health sciences·2026

Engineered subtilisin protease degrades active KRAS in cancer cells leading to differential cell targeting.

Research square·2026

Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

Research square·2026

The therapy-conditioned host: a state-transition framework for second primary cancer evolution.

Frontiers in oncology·2026

Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway.

Frontiers in physiology·2026

Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report.

Frontiers in oncology·2026

Related Experiment Videos

Calpain inhibitor I and colonic inflammation induced by DNBS in the rat

Related Concept Videos

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.

Orlistat in the treatment of obesity.

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis.

Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss.

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.

Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling.

Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.

Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.

Prior endoscopic surveillance and diagnosis of Barrett-related dysplasia and cancer: evidence from a nationwide Dutch cohort.

Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC.

Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.

Engineered subtilisin protease degrades active KRAS in cancer cells leading to differential cell targeting.

Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

The therapy-conditioned host: a state-transition framework for second primary cancer evolution.

Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway.

Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report.

Related Experiment Videos

Calpain inhibitor I and colonic inflammation induced by DNBS in the rat

Related Concept Videos

Related Articles